Skip to main content

MoneyWorks4Me

Jenburkt Pharmaceuticals informs about loss of share certificate

20 Aug 2019 Evaluate

Jenburkt Pharmaceuticals has informed about loss of share certificate / issue of duplicate share certificate, pursuant to Regulation 39(3) of SEBI (Listing obligations and disclosure requirement) Regulations 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1897.80
Dr. Reddys Labs. 1375.85
Cipla 1414.80
Lupin 2016.50
Zydus Lifesciences 1203.65
View more..